Literature DB >> 11518175

Survival times of and prognostic indicators for dogs with heart base masses: 25 cases (1986-1999).

E D Vicari1, D C Brown, D E Holt, D J Brockman.   

Abstract

OBJECTIVE: To determine survival times of and prognostic indicators for dogs with heart base masses.
DESIGN: Retrospective study. ANIMALS: 25 dogs. PROCEDURE: Medical records were reviewed to obtain information regarding signalment; initial complaint; results of physical examination, radiography, electrocardiography, and echocardiography; surgical findings; medical and surgical treatment; outcome; necropsy findings; survival time; and cause of death.
RESULTS: Survival time ranged from 0 to 1,096 days (mean, 213 days; median, 57 days). None of the variables examined, including initial complaints and results of physical examination, radiography, electrocardiography, and echocardiography, were associated with survival time. However, dogs that underwent pericardectomy had a significantly longer mean survival time (mean +/- SD, 661 +/- 170 days) than did dogs that were treated medically (129 +/- 51 days). CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that dogs with heart base masses that undergo pericardectomy may survive longer than those that receive medical treatment alone.

Entities:  

Mesh:

Year:  2001        PMID: 11518175     DOI: 10.2460/javma.2001.219.485

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Caval chemodectoma in a cat.

Authors:  Irene Martinez; Daniel Brockman; Katarzyna Purzycka
Journal:  JFMS Open Rep       Date:  2022-07-05

Review 2.  Review of oncological emergencies in small animal patients.

Authors:  Katrina L Tumielewicz; Danielle Hudak; Jennifer Kim; David W Hunley; Lisa A Murphy
Journal:  Vet Med Sci       Date:  2019-03-21

3.  Use of multidetector computed tomography in the assessment of dogs with pericardial effusion.

Authors:  K F Scollan; B Bottorff; S Stieger-Vanegas; S Nemanic; D Sisson
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.